Covestor’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding VRDN
KCM
Covestor's VRDN Position: Q3 2026 in Review
Covestor reduced its Viridian Therapeutics (VRDN) stake by 41% in Q3 2026, selling an estimated $256 and leaving 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2876.
Covestor first reported a position in VRDN in Q1 2023 and has held it in 15 quarters since. The position peaked at $1K in Q2 2026. 235 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.
- Covestor held 17 shares of Viridian Therapeutics worth $0 as of Q3 2026.
- Covestor sold 12 Viridian Therapeutics shares in Q3 2026, an estimated $256.
- Viridian Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2876 holding.
- Covestor first reported a position in Viridian Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Covestor's Viridian Therapeutics position peaked at $1K in Q2 2026.
- 235 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.